Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-17 Sale |
2020-12-18 4:29 pm |
Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director |
88,764 | $53.55 | $4,753,680 | 5,000 (Direct) |
View |
| 2020-12-01 Sale |
2020-12-03 6:42 pm |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
3,364 | $38.21 | $128,525 | 415,918 (Indirect Direct) |
View |
| 2020-11-27 Sale |
2020-11-27 9:00 pm |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
35,000 | $38.57 | $1,350,000 | 783,267 (Indirect Direct) |
View |
| 2020-11-25 Sale |
2020-11-25 8:02 pm |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
50,000 | $36 | $1,800,000 | 751,001 (Indirect Direct) |
View |
| 2020-11-16 Sale |
2020-11-18 7:56 pm |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
20,000 | $34 | $680,000 | 745,767 (Indirect Direct) |
View |
| 2020-11-16 Sale |
2020-11-18 7:55 pm |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
6,653 | $34.36 | $228,568 | 557,427 (Indirect Direct) |
View |
| 2020-11-04 Sale |
2020-11-06 4:41 pm |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
3,364 | $28 | $94,192 | 414,525 (Indirect Direct) |
View |
| 2020-11-04 Sale |
2020-11-06 4:38 pm |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
50,000 | $26 | $1,300,000 | 801,001 (Indirect Direct) |
View |
| 2020-10-15 Sale |
2020-10-16 8:58 pm |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
5,615 | $24.2 | $135,883 | 418,006 (Indirect Direct) |
View |
| 2020-10-07 Sale |
2020-10-09 4:14 pm |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
5,000 | $21.83 | $109,150 | 851,001 (Indirect Direct) |
View |
| 2020-09-15 Sale |
2020-09-17 4:55 pm |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
5,615 | $21.04 | $118,140 | 423,621 (Indirect Direct) |
View |
| 2020-09-01 Sale |
2020-09-03 4:15 pm |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. President and CEO |
5,000 | $21.83 | $109,150 | 856,001 (Indirect Direct) |
View |
| 2020-08-18 Sale |
2020-08-20 4:13 pm |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
5,615 | $21 | $117,915 | 429,236 (Indirect Direct) |
View |
| 2020-08-06 Sale |
2020-08-07 7:29 pm |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. President and CEO |
5,000 | $21.83 | $109,150 | 861,001 (Indirect Direct) |
View |
| 2020-07-15 Sale |
2020-07-17 4:18 pm |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
5,615 | $22.7 | $127,461 | 434,851 (Indirect Direct) |
View |
| 2020-07-01 Sale |
2020-07-02 4:10 pm |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. President and CEO |
5,000 | $21.83 | $109,150 | 866,001 (Indirect Direct) |
View |
| 2020-06-16 Sale |
2020-06-18 5:00 pm |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
5,615 | $21 | $117,915 | 439,609 (Indirect Direct) |
View |
| 2020-06-03 Sale |
2020-06-05 5:18 pm |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. President and CEO |
5,000 | $21.83 | $109,150 | 871,001 (Indirect Direct) |
View |
| 2020-05-26 Sale |
2020-05-28 5:23 pm |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
5,615 | $21.21 | $119,094 | 445,224 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-12-30 Exercise |
2021-01-04 9:03 pm |
N/A 2027-01-02 |
Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW EVP, Chief Operating Officer |
1,500 | $0 | 161,173 (Direct) |
View |
| 2020-12-30 Exercise |
2021-01-04 9:03 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW EVP, Chief Operating Officer |
1,500 | $13.48 | 161,173 (Direct) |
View |
| 2020-12-17 Exercise |
2020-12-18 4:29 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director |
19,000 | $15.78 | 5,000 (Direct) |
View |
| 2020-12-17 Exercise |
2020-12-18 4:29 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director |
19,000 | $14.35 | 5,000 (Direct) |
View |
| 2020-12-17 Exercise |
2020-12-18 4:29 pm |
N/A 2026-05-04 |
Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director |
88,764 | $0 | 5,000 (Direct) |
View |
| 2020-12-17 Exercise |
2020-12-18 4:29 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director |
31,764 | $18 | 5,000 (Direct) |
View |
| 2020-12-17 Exercise |
2020-12-18 4:29 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director |
19,000 | $25.98 | 5,000 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-03 6:42 pm |
N/A 2027-01-05 |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
5,000 | $0 | 415,918 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-03 6:42 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
5,000 | $13.88 | 415,918 (Direct) |
View |
| 2020-11-27 Exercise |
2020-11-27 9:00 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
20,000 | $14.58 | 783,267 (Direct) |
View |
| 2020-11-27 Exercise |
2020-11-27 9:00 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
15,000 | $18.3 | 783,267 (Direct) |
View |
| 2020-11-27 Exercise |
2020-11-27 9:00 pm |
N/A 2027-12-11 |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
35,000 | $0 | 783,267 (Direct) |
View |
| 2020-11-25 Exercise |
2020-11-25 8:02 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
50,000 | $6.83 | 751,001 (Direct) |
View |
| 2020-11-25 Exercise |
2020-11-25 8:02 pm |
N/A 2026-02-02 |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
50,000 | $0 | 751,001 (Direct) |
View |
| 2020-11-16 Exercise |
2020-11-18 7:56 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
20,000 | $14.58 | 745,767 (Direct) |
View |
| 2020-11-16 Exercise |
2020-11-18 7:56 pm |
N/A 2028-12-17 |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
20,000 | $0 | 745,767 (Direct) |
View |
| 2020-11-16 Exercise |
2020-11-18 7:55 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
10,000 | $6.83 | 557,427 (Direct) |
View |
| 2020-11-16 Exercise |
2020-11-18 7:55 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
1,410 | $18.3 | 557,427 (Direct) |
View |
| 2020-11-16 Exercise |
2020-11-18 7:55 pm |
N/A 2026-02-02 |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
11,410 | $0 | 557,427 (Direct) |
View |
| 2020-11-04 Exercise |
2020-11-06 4:41 pm |
N/A 2027-01-05 |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
5,000 | $0 | 414,525 (Direct) |
View |
| 2020-11-04 Exercise |
2020-11-06 4:41 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
5,000 | $13.88 | 414,525 (Direct) |
View |
| 2020-11-04 Exercise |
2020-11-06 4:38 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
50,000 | $6.83 | 801,001 (Direct) |
View |
| 2020-11-04 Exercise |
2020-11-06 4:38 pm |
N/A 2026-02-02 |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
50,000 | $0 | 801,001 (Direct) |
View |
| 2020-10-15 Exercise |
2020-10-16 8:58 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
10,000 | $6.83 | 418,006 (Direct) |
View |
| 2020-10-15 Exercise |
2020-10-16 8:58 pm |
N/A 2026-02-02 |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
10,000 | $0 | 418,006 (Direct) |
View |
| 2020-10-07 Exercise |
2020-10-09 4:14 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
5,000 | $6.83 | 851,001 (Direct) |
View |
| 2020-10-07 Exercise |
2020-10-09 4:14 pm |
N/A 2026-02-02 |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
5,000 | $0 | 851,001 (Direct) |
View |
| 2020-10-02 Option Award |
2020-10-05 4:15 pm |
N/A 2030-10-01 |
Intellia Therapeutics Inc. | NTLA | Crowley John F Director |
38,000 | $0 | 38,000 (Direct) |
View |
| 2020-09-15 Exercise |
2020-09-17 4:55 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
10,000 | $6.83 | 423,621 (Direct) |
View |
| 2020-09-15 Exercise |
2020-09-17 4:55 pm |
N/A 2026-02-02 |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
10,000 | $0 | 423,621 (Direct) |
View |
| 2020-09-01 Exercise |
2020-09-03 4:15 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. President and CEO |
5,000 | $6.83 | 856,001 (Direct) |
View |
| 2020-09-01 Exercise |
2020-09-03 4:15 pm |
N/A 2026-02-02 |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. President and CEO |
5,000 | $0 | 856,001 (Direct) |
View |
| 2020-08-18 Exercise |
2020-08-20 4:13 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
10,000 | $6.83 | 429,236 (Direct) |
View |
| 2020-08-18 Exercise |
2020-08-20 4:13 pm |
N/A 2026-02-02 |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
10,000 | $0 | 429,236 (Direct) |
View |
| 2020-08-06 Exercise |
2020-08-07 7:29 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. President and CEO |
5,000 | $6.83 | 861,001 (Direct) |
View |
| 2020-08-06 Exercise |
2020-08-07 7:29 pm |
N/A 2026-02-02 |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. President and CEO |
5,000 | $0 | 861,001 (Direct) |
View |
| 2020-07-15 Exercise |
2020-07-17 4:18 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
10,000 | $6.83 | 434,851 (Direct) |
View |
| 2020-07-15 Exercise |
2020-07-17 4:18 pm |
N/A 2026-02-02 |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
10,000 | $0 | 434,851 (Direct) |
View |
| 2020-07-01 Exercise |
2020-07-02 4:10 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. President and CEO |
5,000 | $6.83 | 866,001 (Direct) |
View |
| 2020-07-01 Exercise |
2020-07-02 4:10 pm |
N/A 2026-02-02 |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. President and CEO |
5,000 | $0 | 866,001 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-19 5:13 pm |
N/A 2030-06-17 |
Intellia Therapeutics Inc. | NTLA | Cohen Fred E Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-19 4:47 pm |
N/A 2030-06-17 |
Intellia Therapeutics Inc. | NTLA | Verwiel Frank Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-19 4:46 pm |
N/A 2030-06-17 |
Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-19 4:45 pm |
N/A 2030-06-17 |
Intellia Therapeutics Inc. | NTLA | GOODMAN JESSE Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-19 4:44 pm |
N/A 2030-06-17 |
Intellia Therapeutics Inc. | NTLA | FORMELA JEAN FRANCOIS Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-19 4:44 pm |
N/A 2030-06-17 |
Intellia Therapeutics Inc. | NTLA | DORSA CAROLINE Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2020-06-16 Exercise |
2020-06-18 5:00 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
10,000 | $6.83 | 439,609 (Direct) |
View |
| 2020-06-16 Exercise |
2020-06-18 5:00 pm |
N/A 2026-02-02 |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
10,000 | $0 | 439,609 (Direct) |
View |
| 2020-06-03 Exercise |
2020-06-05 5:18 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. President and CEO |
5,000 | $6.83 | 871,001 (Direct) |
View |
| 2020-06-03 Exercise |
2020-06-05 5:18 pm |
N/A 2026-02-02 |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M. President and CEO |
5,000 | $0 | 871,001 (Direct) |
View |
| 2020-05-26 Exercise |
2020-05-28 5:23 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
10,000 | $6.83 | 445,224 (Direct) |
View |
| 2020-05-26 Exercise |
2020-05-28 5:23 pm |
N/A 2026-02-02 |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
10,000 | $0 | 445,224 (Direct) |
View |
| 2020-05-01 Option Award |
2020-05-05 4:49 pm |
N/A 2030-04-30 |
Intellia Therapeutics Inc. | NTLA | Lebwohl David EVP, Chief Medical Officer |
200,000 | $0 | 200,000 (Direct) |
View |